The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier
Open accessAbstract
AIM: To investigate whether gut microbiota metabolite sodium butyrate (NaB) is an effective substance for attenuating non-alcoholic fatty liver disease (NAFLD) and the internal mechanisms. METHODS: Male C57BL/6J mice were divided into three groups, normal control were fed standard chow and model group were fed a high-fat diet (HFD) for 16 wk, the intervention group were fed HFD for 16 wk and treated with NaB for 8 wk. Gut microbiota from each group were detected at baseline and at 16 wk, liver histology were evaluated and gastrointestinal barrier indicator such as zonula occluden-1 (ZO-1) were detected by immunohistochemistry and realtime-PCR, further serum or liver endotoxin were determined by ELISA and inflammation- or metabolism-associated genes were quantified by real-time PCR. RESULTS: . These bacteria can produce butyric acid in what seems like a virtuous circle. And butyrate restored HFD induced intestinal mucosa damage, increased the expression of ZO-1 in small intestine, further decreased the levels of gut endotoxin in serum and liver compared with HF group. Endotoxin-associated genes such as TLR4 and Myd88, pro-inflammation genes such as MCP-1, TNF-α, IL-1, IL-2, IL-6 and IFN-γ in liver or epididymal fat were obviously downregulated after NaB intervention. Liver inflammation and fat accumulation were ameliorated, the levels of TG and cholesterol in liver were decreased after NaB intervention, NAS score was significantly decreased, metabolic indices such as FBG and HOMA-IR and liver function indicators ALT and AST were improved compared with HF group. CONCLUSION: NaB may restore the dysbiosis of gut microbiota to attenuate steatohepatitis, which is suggested to be a potential gut microbiota modulator and therapeutic substance for NAFLD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Zhou et al. reported that sodium butyrate (NaB) reduced the entry of inflammatory factors into the liver by regulating gut microbial dysbiosis, thereby reducing steatohepatitis induced by a high-fat diet [21].”
From Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson’s Disease (2023) · cites this paper as [21]
Citations
Cites
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 21,481
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
The gut microbiota--masters of host development and physiology
Sommer, F., & Bäckhed, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2974 · Cited by 3,681
Human Genetics Shape the Gut Microbiome
Goodrich, J. K., Waters, J. L., Poole, A. C., Sutter, J. L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J. T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.053 · Cited by 3,164
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 442
Nozu, T., Miyagishi, S., Nozu, R., Takakusaki, K., & Okumura, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-56132-4 · Cited by 56
Yu, Q., Dai, W., Ji, J., Wu, L., Feng, J., Li, J., Zheng, Y., Li, Y., Cheng, Z., Zhang, J., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17322 · Cited by 56
Zhang, R., Yan, Z., Zhong, H., Rong, L., Liu, W., Xiong, S., Liu, Q., & Liu, M. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000484 · Cited by 57
Self-citationYe, J., Wu, Z., Zhao, Y., Zhang, S., Liu, W.-T., & Su, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1029890 · Cited by 58
NAFLD, Helicobacter species and the intestinal microbiome
Castaño‐Rodríguez, N., Mitchell, H. M., & Kaakoush, N. O. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.09.008 · Cited by 53
de Sousa, A. R., Moreira, M. E. D. C., Grancieri, M., Toledo, R. C. L., Araújo, F. D. O., Mantovani, H. C., Queiróz, V. A. V., & Martino, H. S. D. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.05.009 · Cited by 54
The role of gut microbiota in liver disease development and treatment
Wang, L., & Wan, Y. Y. (2019) · Liver Research · doi:10.1016/j.livres.2019.02.001 · Cited by 53
Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis
Baumann, A., Jin, C. J., Brandt, A., Sellmann, C., Nier, A., Burkard, M., Venturelli, S., & Bergheim, I. (2020) · Nutrients · doi:10.3390/nu12040951 · Cited by 51
Xu, Y., Huang, X., Huangfu, B., Hu, Y., Xu, J., Gao, R., Huang, K., & He, X. (2023) · Nutrients · doi:10.3390/nu15030743 · Cited by 52
Leng, J., Huang, F., Hai, Y., Tian, H., Liu, W., Fang, Y., Hu, Y., & Peng, J. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.153135 · Cited by 50
Gart, E., van Duyvenvoorde, W., Toet, K. H., Caspers, M. P. M., Verschuren, L., Nielsen, M. J., Leeming, D. J., Lima, E. S., Menke, A. L., Hanemaaijer, R., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9121954 · Cited by 49
Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD)
Guo, Q., Li, Y., Dai, X., Wang, B., Zhang, J., & Cao, H. (2023) · Nutrients · doi:10.3390/nu15173722 · Cited by 50
Dua, A., KUMARI, R. R., Singh, M., Kumar, R., Pradeep, S., Ojesina, A. I., & Kumar, R. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1618275 · Cited by 53
Li, L., Wang, H., Zhang, N., Zhang, T., & Ma, Y. (2022) · Journal of Animal Science · doi:10.1093/jas/skac046 · Cited by 48
Dang, G., Wang, W., Zhong, R., Wu, W., Chen, L., & Zhang, H. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1069694 · Cited by 48
Gao, Y., Yang, L., Chin, Y., Liu, F., Li, R. W., Yuan, S., Xue, C., Xu, J., & Tang, Q. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062149 · Cited by 49
Metformin Mitigates Sepsis-Related Neuroinflammation via Modulating Gut Microbiota and Metabolites
Zhao, H., Lyu, Y., Zhai, R., Sun, G., & Ding, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.797312 · Cited by 48
Zhao, H., Bai, H., Deng, F., Zhong, R., Liu, L., Chen, L., & Zhang, H. (2022) · Antibiotics · doi:10.3390/antibiotics11020132 · Cited by 53
Yang, N., Lan, T., Han, Y., Zhao, H., Wang, C., Xu, Z. C., Zhao, C., Tao, M., Li, H., Song, Y., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289364 · Cited by 50
Guo, B., Liu, B., Wei, H., Cheng, K., & Chen, F. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800808 · Cited by 45
Maternal microbiome in preeclampsia pathophysiology and implications on offspring health
Ishimwe, J. A. (2021) · Physiological Reports · doi:10.14814/phy2.14875 · Cited by 45
Dagbasi, A., Lett, A. M., Murphy, K., & Frost, G. (2020) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120006941 · Cited by 44
Guo, J., Zhang, M., Wang, H., Li, N., Lu, Z., Li, L., Hui, S., & Xu, H. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14063 · Cited by 48
Hamamah, S., Iatcu, O. C., & Covașă, M. (2024) · Nutrients · doi:10.3390/nu17010143 · Cited by 52
Trichostatin A and sodium butyrate promotes plant regeneration in common wheat
Bie, X. M., Dong, L., Li, X. H., Wang, H., Gao, X.-Q., & Li, X. G. (2020) · Plant Signaling & Behavior · doi:10.1080/15592324.2020.1820681 · Cited by 44
Evidence for Modulation of Substance Use Disorders by the Gut Microbiome: Hidden in Plain Sight
Angoa‐Pérez, M., & Kuhn, D. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000144 · Cited by 44
Wang, T., Ye, Y., Ji, J., Yang, X., Xu, J., Wang, J.-S., Han, X., Zhang, T., & Sun, X. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113466 · Cited by 44
Yi, X., Ren, M., Yang, J., Cai, C., Cheng, W., Zhou, X., Lu, D., & Ji, F. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1003755 · Cited by 46
Xin, F., Zhao, Z., Zhang, R.-N., Pan, Q., Gong, Z., Sun, C., & Fan, J. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i18.2203 · Cited by 44
Self-citationIntestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver disease
Nawrot, M., Peschard, S., Lestavel, S., & Staels, B. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154844 · Cited by 49
Amiri, P., Arefhosseini, S., Bakhshimoghaddam, F., Gurvan, H. J., & Hosseini, S. A. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1037696 · Cited by 42
García-Gutiérrez, E., O’Mahony, A. K., dos Santos, R. S., Marroquí, L., & Cotter, P. D. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2401654 · Cited by 43
Jirsova, Z., Heczková, M., Daňková, H., Malínská, H., Videnska, P., Vespalcová, H., Micenková, L., Bartoňová, L., Sticová, E., Lodererová, A., et al. (2019) · BioMed Research International · doi:10.1155/2019/7084734 · Cited by 41
Structural modulation of gut microbiota reveals Coix seed contributes to weight loss in mice
Liu, S., Li, F., & Zhang, X. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09786-z · Cited by 41
Yong, W., Zhao, Y., Jiang, X., & Li, P. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.15279 · Cited by 40
Astilbin from Smilax glabra Roxb. alleviates high-fat diet-induced metabolic dysfunction
Wang, T., Ye, Y., Ji, J., Zhang, S., Yang, X., Xu, J., Wang, J.-S., Chen, Z., Xia, B., Shen, H., et al. (2022) · Food & Function · doi:10.1039/d2fo00060a · Cited by 40
Gómez‐Zorita, S., Aguirre, L., Milton‐Laskibar, I., Fernández‐Quintela, A., Trepiana, J., Kajarabille, N., Mosqueda-Solís, A., González, M. A., & Portillo, M. P. (2019) · Nutrients · doi:10.3390/nu11092156 · Cited by 40
Modulation effect of chenpi extract on gut microbiota in high‐fat diet‐induced obese C57BL/6 mice
Li, A., Wang, N., Li, N., Li, B., Yan, F., Song, Y., Hou, J., & Huo, G. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13541 · Cited by 40
Butyrate as a potential therapeutic agent for neurodegenerative disorders
Chakraborty, P., Gamage, H. K. A. H., & Laird, A. S. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105745 · Cited by 44
Zhang, T., Li, J., Liu, C., Guo, M., Gao, C., Zhou, L., Long, Y., & Xu, Y. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2158 · Cited by 39
Self-citationLa, A. L. T. Z., Feng, Y., Hu, D., Feng, Y., Jin, X., Liu, D., Guo, Y., Cheng, G., & Hu, Y. (2023) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-023-00887-4 · Cited by 43
Qu, D., Chen, M., Zhu, H., Liu, X., Cui, Y., Zhou, W., & Zhang, M. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149131 · Cited by 42
Liu, W.-W., Yu, L., Chen, Q., Zhang, C., Wang, L., Yu, N., Peng, D., Ou, J., Chen, W., Zhang, Y., et al. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116671 · Cited by 38
Moretó, M., Miró, L., Amat, C., Polo, J., Manichanh, C., & Pérez‐Bosque, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-59756-z · Cited by 39
Lan, J., Chen, G., Cao, G., Tang, J., Li, Q., Zhang, B., & Yang, C. (2020) · Poultry Science · doi:10.1016/j.psj.2020.11.052 · Cited by 46
Self-citationHuang, Y., Ding, Y., Xu, H., Shen, C., Chen, X., & Li, C. (2021) · Helicobacter · doi:10.1111/hel.12785 · Cited by 37
Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases
Liu, C., Wang, Y., Yang, Y., Zhang, N., Niu, C., Shen, X., & Wu, J. H. (2021) · The FASEB Journal · doi:10.1096/fj.202100939r · Cited by 37
Self-citationPengrattanachot, N., Thongnak, L., & Lungkaphin, A. (2022) · Food & Function · doi:10.1039/d1fo04428a · Cited by 37
Bilson, J., Sethi, J. K., & Byrne, C. D. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121003815 · Cited by 37
Sun, L., Tan, X., Liang, X., Chen, H., Ou, Q., Wu, Q., Yu, X., Zhao, H., Huang, Q., Yi, Z., et al. (2023) · Nutrients · doi:10.3390/nu15020284 · Cited by 36
Gut Microbiome-Based Therapeutics in Critically Ill Adult Patients—A Narrative Review
He, S., Lin, F., Hu, X., & Pan, P. (2023) · Nutrients · doi:10.3390/nu15224734 · Cited by 36
Prebiotics, probiotics, synbiotics and postbiotics to adolescents in metabolic syndrome
Luzzi, A., Briata, I. M., Napoli, I. D., Giugliano, S., Sabatino, A. D., Rescigno, M., & Cena, H. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.04.032 · Cited by 42
The contribution of the gut-liver axis to the immune signaling pathway of NAFLD
Liu, J., Wu, A., Cai, J., She, Z., & Li, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.968799 · Cited by 42
The immune response as a therapeutic target in non-alcoholic fatty liver disease
Ortiz‐López, N., Fuenzalida, C., Dufeu, M. S., Pinto-León, A., Escobar, A. F., Poníachik, J., Roblero, J. P., Valenzuela-Pérez, L., & Beltrán, C. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954869 · Cited by 37
Butyrate Lowers Cellular Cholesterol through HDAC Inhibition and Impaired SREBP-2 Signalling
Bridgeman, S. C., Woo, H. C., Newsholme, P., & Mamotte, C. D. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415506 · Cited by 41
Nelson, B. N., & Friedman, J. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115951 · Cited by 39
Jiménez-González, C., Alonso‐Peña, M., Vélez, P. A., Crespo, J., & Iruzubieta, P. (2025) · Nutrients · doi:10.3390/nu17091580 · Cited by 40
Chen, Y., Zhao, S., Jiao, D., Yao, B., Yang, S., Li, P., & Long, M. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8894491 · Cited by 35
Self-citationRajcic, D., Baumann, A., Hernández-Arriaga, A. M., Brandt, A., Nier, A., Jin, C. J., Sánchez, V., Jung, F., Camarinha‐Silva, A., & Bergheim, I. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101879 · Cited by 34
The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD
Huang, W., & Kong, D. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111235 · Cited by 38
Li, Y., Liangjie, Z., Hou, M., Gao, T., Sun, J., Luo, H., Wang, F., Zhong, F., Ma, A., & Cai, J. (2022) · Nutrients · doi:10.3390/nu14081668 · Cited by 34
Early intestinal microbiota changes in aged and adult mice with sepsis
Yuan, Y., Liu, S., Ding, X., Li, Y., Zhang, X., Song, H., Qi, X., Zhang, Z., Guo, K., & Sun, T. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1061444 · Cited by 35
Liu, Q., Cheng, L., Wang, M., Shen, L., Zhang, C., Mu, J., Hu, Y., Yang, Y., He, K., Yan, H., et al. (2024) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-024-01009-4 · Cited by 35
Yi, C., Sun, W. C., Ding, L., Yan, M., Sun, C. L., Qiu, C., Wang, D., & Wu, L. (2022) · Molecules · doi:10.3390/molecules27248801 · Cited by 35
Chen, W.-J., Chen, Y.-T., Ko, J., Chen, J.-Y., Zheng, J.-Y., Liao, J., & Ou, C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117689 · Cited by 34
Self-citationSun, J., Zhao, F., Lin, B., Feng, J., Wu, X. F., Liu, Y., Zhao, L., Zhu, B., & Wei, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.598170 · Cited by 35
Kang, Y., Ren, P., Shen, X., Kuang, X., Yang, X., Liu, H., Yan, H., Yang, H., Kang, X., Ding, Z., et al. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300141 · Cited by 33
Metabolomic Biomarkers in the Diagnosis of Non-Alcoholic Fatty Liver Disease
Chashmniam, S., Ghafourpour, M., Farimani, A. R., Gholami, A., & Gh, B. F. N. M. (2019) · Hepatitis Monthly · doi:10.5812/hepatmon.92244 · Cited by 33
Streptococcus thermophiles DMST-H2 Promotes Recovery in Mice with Antibiotic-Associated Diarrhea
Hu, J., Huang, Y., Kuang, J., Yu, J., Zhou, Q.-Y., & Liu, D. (2020) · Microorganisms · doi:10.3390/microorganisms8111650 · Cited by 33
Guo, J., Wang, P., Cui, Y., Hu, X., Chen, F., & Ma, C. (2023) · Nutrients · doi:10.3390/nu15041043 · Cited by 33
Williams, L. M., & Cao, S. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108605 · Cited by 33
Cai, T., Song, X., Xu, X., Dong, L., Liang, S., Xin, M., Huang, Y., Zhu, L., Li, T., Wang, X., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1323261 · Cited by 32
Bakshi, J., & Mishra, K. P. (2024) · Cellular Immunology · doi:10.1016/j.cellimm.2024.104912 · Cited by 34
Fang, Q., Li, X., Wang, M., Qiao, X., Huang, F., Hu, C., Xue, Y., Zhao, S., & Lin, Y. (2022) · Food & Function · doi:10.1039/d2fo00012a · Cited by 31
Prins, G. H., Ríos-Morales, M., Gerding, A., Reijngoud, D., Olinga, P., & Bakker, B. M. (2021) · Nutrients · doi:10.3390/nu13124203 · Cited by 30
Acupuncture influences multiple diseases by regulating gut microbiota
Xu, H., Luo, Y., Li, Q., & Zhu, H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1371543 · Cited by 33
Gegen Qinlian Decoction Attenuates High‐Fat Diet‐Induced Steatohepatitis in Rats via Gut Microbiota
Guo, Y., Ding, P., Liu, L., Shi, L., Mao, T., Li, J., & Wang, Y.-L. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/7370891 · Cited by 30
Freeze-dried Si-Ni-San powder can ameliorate high fat diet-induced non-alcoholic fatty liver disease
Zhu, F., Li, Y.-M., Feng, T.-T., Wu, Y., Zhang, H., Jin, G., & Liu, J. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i24.3056 · Cited by 31
Yang, L., Kang, X., Dong, W., Wang, L., Liu, S., Zhong, X., & Liu, D. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105069 · Cited by 33
Wang, J., Han, X., Li, J., Shi, R., Liu, L., Wang, K., Liao, Y.-T., Jiang, H., Zhang, Y., Hu, J., et al. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i43.6109 · Cited by 28
Lv, S., Zhang, Z., Su, X., Li, W., Wang, X., Pan, B., Li, H., Zhang, H., & Wang, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1106875 · Cited by 30
Wang, H., Ma, C., Li, Y., Zhang, L., lima, A., Yang, C., Zhao, F., Han, H., Shang, D., Yang, F., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04440-22 · Cited by 34
Hu, C., Zeng, D., Huang, Y., Deng, Q., Liu, S., Zhou, W., & Zhou, W. (2023) · Inflammation · doi:10.1007/s10753-023-01955-7 · Cited by 29
Li, Y., Liu, M., Liu, H., Wei, X., Su, X.-H., Li, M., & Yuan, J. (2020) · BioMed Research International · doi:10.1155/2020/9067821 · Cited by 32
Zhang, L., Ma, Z., Zhang, X., Wang, J., Tian, W., Ren, Y., Liu, Y., Wang, T., Li, Y., Liu, Y., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111852 · Cited by 28
Li, H., Wu, Y., Zhou, Q., Wu, P., Xing, Y., Zhuang, Z., Zhao, X., & Zhang, X. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140343 · Cited by 31
Wu, D., Cao, M., Li, N., Zhang, A., Yu, Z., Cheng, J., Xie, X., Wang, Z., Lu, S., Yan, S., et al. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106026 · Cited by 27
Xia, T., Yao, Y., Wang, C., Dong, M., Wu, Y., Li, D., Xie, M., Ni, Q., Zhang, M., & Xu, H. (2020) · Global Ecology and Conservation · doi:10.1016/j.gecco.2020.e01409 · Cited by 27
Liu, H.-J., Cao, S., Wen, B., Han, X., Li, Y., Li, S., Li, J., & Zhang, L. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108065 · Cited by 28
Xiao, L., Xiong, H., Deng, Z., Peng, X. X., Cheng, K., Zhang, H., Jiang, L., & Sun, Y. (2022) · Food & Function · doi:10.1039/d2fo03028d · Cited by 28
The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver disease
Mai, H., Yang, X. H., Xie, Y., Zhou, J., Wang, Q., Wei, Y., Yang, Y., Lu, D., Ye, L., Cui, P., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1257903 · Cited by 27
Overview of the microbiota in the gut-liver axis in viral B and C hepatitis
Neag, M. A., Mitre, A. O., Cătinean, A., & Buzoianu, A. D. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i43.7446 · Cited by 27
Wang, Y., Zhang, Y., Yang, J., Li, H., Wang, J., & Geng, W. (2021) · Foods · doi:10.3390/foods10123126 · Cited by 26
Yang, L., Dai, Y., He, H., Liu, Z., Liao, S., Zhang, Y., Liao, G., & An, Z. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.969757 · Cited by 26
Targets of statins intervention in LDL-C metabolism: Gut microbiota
Sun, C., Wang, Z., Hu, L., Zhang, X., Chen, J., Yu, Z., Liu, L., & Wu, M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.972603 · Cited by 26
Zhong, L., Lyu, W., Lin, Z., Lu, J. F., Geng, Y., Song, L., & Zhang, H. (2023) · Foods · doi:10.3390/foods12091780 · Cited by 26
Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic Steatohepatitis
Satapathy, S. K., Banerjee, P., Pierre, J. F., Higgins, D., Dutta, S., Heda, R. P., Khan, S. D., Mupparaju, V. K., Mas, V. R., Nair, S. P., et al. (2020) · Transplantation Direct · doi:10.1097/txd.0000000000001033 · Cited by 25
Zhao, C., Xie, L., Shen, J., He, H., Zhang, T., Hao, L., Sun, C., Zhang, X., Chen, M., Liu, F., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140287 · Cited by 24
Zhang, M., Zou, X., Zhao, D., Zhao, F., & Li, C. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201901105 · Cited by 24
Ye, L., Zhang, Q., Xin, F., Cao, B., Qian, L., & Dong, Y. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.621957 · Cited by 24
Self-citation
Metadata
- Authors
- Zhou, D., Pan, Q., Xin, F.-Z., Zhang, R.-N., He, C.-X., Chen, G.-Y., Liu, C., Chen, Y.-W., & Fan, J.-G.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2017
- Volume
- 23
- Issue
- 1
- Pages
- 60
- ISSN
- 1007-9327 (ISSN-L)
- PMC
- PMC5221287
- OpenAlex
- W2571212804
- Cited by
- 441
- References
- 56
- Citations by year
- 2026: 34 · 2025: 61 · 2024: 66 · 2023: 58 · 2022: 68 · 2021: 46 · 2020: 50 · 2019: 30 · 2018: 17 · 2017: 11
- FWCI
- 12.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- World Journal of Gastroenterology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- sodium butyrate, non-alcoholic fatty liver disease, steatohepatitis, high-fat diet, gut microbiota, intestinal barrier, zonula occludens-1, endotoxin, gut-liver axis, gut dysbiosis, inflammation, insulin resistance, butyrate
- MeSH terms
- Gastrointestinal Microbiome, Animals, Drug Evaluation, Preclinical, Humans, Immunohistochemistry, Inflammation, Intestinal Mucosa, Lactobacillus, Liver, Liver Function Tests, Male, Mice, Inbred C57BL, Specific Pathogen-Free Organisms, Tumor Necrosis Factor-alpha, Cytokines, Butyric Acid, Mice, Diet, High-Fat, Real-Time Polymerase Chain Reaction, Zonula Occludens-1 Protein, Dysbiosis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review